1. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021; 143(21):e984-e1010. doi:10.1161/CIR.0000000000000973 PMid:33882682 PMCid:PMC8493650

2. World Health Organization. Obesity and overweight. Fact sheet No. 311. Geneva: World Health Organization; 2024.

3. Stefan N, Häring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2023; 11(4):262-272.

4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292(14):1724-1737. doi:10.1001/jama.292.14.1724 PMid:15479938

5. Jakubiak GK, Osadnik K, Lejawa M, Osadnik T, Goławski M, Lewandowski P, et al. "Obesity and insulin resistance" is the component of the metabolic syndrome most strongly associated with oxidative stress. Antioxidants (Basel). 2022;11(1):79. doi:10.3390/antiox11010079 PMid:35052583 PMCid:PMC8773170

6. Biswas SK, Rahman I. Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med. 2009;30(1-2):60-76. doi:10.1016/j.mam.2008.07.001 PMid:18760298 PMCid:PMC2699458

7. Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018; 178(5):533-544. doi:10.1530/EJE-17-0883 PMid:29535168

8. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258. doi:10.3389/fpubh.2017.00258 PMid:29034226

9. Lauer M, Froelicher ES, Williams M, Kligfield P. Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2005;112(5):771-776. doi:10.1161/CIRCULATIONAHA.105.166543 PMid:15998671

10. Kangas P, Tikkakoski A, Uitto M, Viik J, Bouquin H, Niemelä O, et al. Metabolic syndrome is associated with decreased heart rate variability in a sex-dependent manner: a comparison between 252 men and 249 women. Clin Physiol Funct Imaging. 2019;39(2):160-167. doi:10.1111/cpf.12551 PMid:30307694

11. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305-313. doi:10.1056/NEJMoa020245 PMid:12151467

12. Robillard ME, Bellefeuille P, Comtois AS, Aubertin-Leheudre M, Karelis AD. The metabolically healthy but obese postmenopausal woman presents a favourable heart rate variability profile. Scand Cardiovasc J. 2011;45(4):217-223. doi:10.3109/14017431.2011.591818 PMid:21726156

13. Rastović M, Srdić Galić B, Barak O, Stokić E, Vasiljev R. Heart rate variability in metabolically healthy and metabolically unhealthy obese premenopausal women. Exp Clin Endocrinol Diabetes. 2019;127(7):446-452.

14. Lear SA, Gasevic D. Ethnicity and metabolic syndrome: implications for assessment, management and prevention. Nutrients. 2020;12(1):15. doi:10.3390/nu12010015 PMid:31861719 PMCid:PMC7019432

15. Wang YC, Liang CS, Gopal DM, Ayalon N, Donohue C, Santhanakrishnan R, et al. Preclinical systolic and diastolic dysfunctions in metabolically healthy and unhealthy obese individuals. Circ Heart Fail. 2015;8(5):897-904. doi:10.1161/CIRCHEARTFAILURE.114.002026 PMid:26175540 PMCid:PMC4573845

16. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998; 97(19):1907-1911. doi:10.1161/01.CIR.97.19.1907 PMid:9609083

17. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA study. J Am Coll Cardiol. 2008;52(25):2148-2155. doi:10.1016/j.jacc.2008.09.014 PMid:19095132 PMCid:PMC2706368

18. Ortiz-Guzmán JE, Mollà-Casanova S, Serra-Añó P, Arias-Mutis ÓJ, Calvo C, Bizy A, et al. Short-term heart rate variability in metabolic syndrome: a systematic review and meta-analysis. J Clin Med. 2023;12(18):6051. doi:10.3390/jcm12186051 PMid:37762990 PMCid:PMC10532399

19. Ortiz-Guzman JE, Molla-Casanova S, Arias-Mutis OJ, Bizy A, Calvo C, Alberola A, et al. Differences in long-term heart rate variability between subjects with and without metabolic syndrome: a systematic review and meta-analysis. J Cardiovasc Dev Dis. 2023;10(5):203. doi:10.3390/jcdd10050203 PMid:37233170 PMCid:PMC10218942

20. Besnier F, Labrunée M, Pathak A, Pavy-Le Traon A, Gerdelat A, Sénard JM, et al. Exercise training-induced modification in autonomic nervous system activity: a systematic review on the effects of intensity. Ann Phys Rehabil Med. 2021; 64(2):101461.

21. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956-966. doi:10.1177/2047487315623884 PMid:26701871 PMCid:PMC5408160

22. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA. 2000; 284(11):1392-1398. doi:10.1001/jama.284.11.1392 PMid:10989401

23. Hainsworth R. The control and physiological importance of heart rate. In: Malik M, Camm AJ, editors. Heart rate variability. Armonk (NY): Futura Publishing Company; 1995. p. 3-19.

24. Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, MacPhee AA, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982; 66(1):55-60. doi:10.1161/01.CIR.66.1.55 PMid:7083520

25. Mirr M, Skrypnik D, Bogdański P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021; 44(12):2831-2843. doi:10.1007/s40618-021-01608-2 PMid:34132976 PMCid:PMC8572197

26. Apykhtin K, Drozdovska S, Gurenko O, Panchenko Y, Andreeva O, Nahorna A, et al. Heart rate variability in people with metabolic syndrome. Aging Longev. 2023;4(1):3-11. doi:10.47855/jal9020-2023-1-1

27. Soomra H, Mukhtar A, Asif F, Khalid A, Noureen S, Qamar Z, et al. (December 10, 2025) Autonomic Nervous System Dysregulation in Metabolic Syndrome: An Association With Hypertension and Cardiovascular Risk. Cureus 17(12): e98932 .doi 10.7759/cureus.98932

28. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339

29. Freeman R, Chapleau MW. Testing the autonomic nervous system. Handb Clin Neurol. 2022;189:129-147.

30. Saeedi Moghaddam S, Masinae M, Rezae N, Mohammadi Fateh S, Dilmaghani-Marand A, Abdolhamidi A, et al. Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults. 2019;19(3):145-152. doi:10.1371/journal. pone.0262246